BrightInsight fetches $101m Series C

BrightInsight, a provider of a global regulated digital health platform for biopharma and medtech, has secured $101 million in Series C financing.

30 March 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles